Volker Herrmann, CEO of Sonata Therapeutics & CEO-Partner at Flagship Pioneering, explains how cancer cells can be reprogrammed to rewire the tumor microenvironment and drive a cure, as well as what makes Sonata one of the best places to work in in biotech. More from Flagship @ JPM2023 here.
Related Companies
- Sonata Therapeutics Founded: 2022
